1. Home
  2. STKH vs DCOY Comparison

STKH vs DCOY Comparison

Compare STKH & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$0.39

Market Cap

566.1K

ML Signal

HOLD

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

HOLD

Current Price

$1.11

Market Cap

674.8K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKH
DCOY
Founded
2018
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.1K
674.8K
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
STKH
DCOY
Price
$0.39
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 229.0K
56.2K
Earning Date
08-25-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$218.44
$20.42
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.53
52 Week High
$7.10
$67.68

Technical Indicators

Market Signals
Indicator
STKH
DCOY
Relative Strength Index (RSI) 26.17 37.90
Support Level $0.33 $0.90
Resistance Level $0.64 $3.29
Average True Range (ATR) 0.06 0.09
MACD 0.06 0.07
Stochastic Oscillator 34.33 66.67

Price Performance

Historical Comparison
STKH
DCOY

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industry through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures, such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: